| 000 | 01710 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518074216.0 | ||
| 264 | 0 | _c20201231 | |
| 008 | 202012s 0 0 eng d | ||
| 022 | _a1873-7064 | ||
| 024 | 7 |
_a10.1016/j.neuropharm.2019.107910 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLin, Fang-Yu | |
| 245 | 0 | 0 |
_aRelative D3 vitamin deficiency and consequent cognitive impairment in an animal model of Alzheimer's disease: Potential involvement of collapsin response mediator protein-2. _h[electronic resource] |
| 260 |
_bNeuropharmacology _c03 2020 |
||
| 300 |
_a107910 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xcomplications |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCholecalciferol |
| 650 | 0 | 4 |
_aCognitive Dysfunction _xetiology |
| 650 | 0 | 4 | _aDietary Supplements |
| 650 | 0 | 4 |
_aHippocampus _xmetabolism |
| 650 | 0 | 4 |
_aIntercellular Signaling Peptides and Proteins _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMaze Learning _xdrug effects |
| 650 | 0 | 4 | _aMemory |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Neurologic Mutants |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xgenetics |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xgenetics |
| 650 | 0 | 4 |
_aVitamin D _xtherapeutic use |
| 650 | 0 | 4 |
_aVitamin D Deficiency _xcomplications |
| 700 | 1 | _aLin, Yu-Fen | |
| 700 | 1 | _aLin, Yung-Shuen | |
| 700 | 1 | _aYang, Chun-Ming | |
| 700 | 1 | _aWang, Che-Chuan | |
| 700 | 1 | _aHsiao, Ya-Hsin | |
| 773 | 0 |
_tNeuropharmacology _gvol. 164 _gp. 107910 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuropharm.2019.107910 _zAvailable from publisher's website |
| 999 |
_c30421664 _d30421664 |
||